SUCO

Across TCGA pan-cancer cohorts, SUCO mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SUCO data layer compared with 21 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher SUCO mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SUCO expression acts as an unfavorable survival marker.

PDAC, LSCC, and HNSC are the cancer types where SUCO mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Tertile	All	0.617	0.860	<.001	66	view →
LSCC	DFS	Median	All	0.601	0.820	.016	9	view →
HNSC	OS	Median	III,IV	0.668	0.952	.038	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SUCO–PDAC (DFS)

Open the PDAC breakdown →